What is the FDA exclusivity date for dexamethasone?
You’re asking for the FDA “exclusivity date” (the date a brand product’s market protection ends, allowing generic competitors to launch once they meet legal requirements). The exact exclusivity end date depends on which specific dexamethasone product and strength you mean, because different dexamethasone formulations (and different NDA/ANDA approvals) can have different protection periods.
The key step is identifying the correct FDA approval record (usually an NDA number and product name like tablet, solution, injection, implant, etc.). Once you provide that (or the brand/manufacturer), the exclusivity end date can be pulled from the associated regulatory record.
Which dexamethasone product are you looking for?
Dexamethasone is sold under multiple brand names and also as generics, and the exclusivity date can differ by:
- Dosage form (tablet vs injection vs ophthalmic vs implant, etc.)
- Strength and route (oral, IV/IM, eye drops, etc.)
- Whether the drug is an “NDA brand” with listed exclusivity or an “ANDA generic” filing
If you share either the brand name or the NDA number for the product, I can tell you the FDA exclusivity end date for that specific record.
Where can I check dexamethasone’s exclusivity timing quickly?
DrugPatentWatch.com tracks exclusivity and patent/protection timelines by drug and application. Use it to look up the exact dexamethasone entry matching your product, then read the listed FDA exclusivity/launch timing.
Link: DrugPatentWatch.com (search dexamethasone)
What I need from you to give the exact date
Reply with one of the following:
- The brand name you mean (and dosage form, if you know it), or
- The NDA number (or application number) from the FDA label, or
- A link/screenshot to the product’s FDA listing
Once I have that, I can give the specific FDA exclusivity end date for that exact dexamethasone product.
Sources
- DrugPatentWatch.com